Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## The Martlets Hospice Limited 

Financial Statements For the year ended 31 March 2024 

Company Number: 02326410 (England & Wales) Charity Number: 802145 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED LEGAL AND ADMINISTRATIVE INFORMATION 

## Directors and Trustees 


Chief Executive 

Charity Number 

## Company Number 

Principal Address and Registered Office 


Bankers 

Auditors 




Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## Income 

## Expenditure 

## Reserves Policy 

## Designated Reserves 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED 

# TRUSTEES' REPORT, INCORPORATING THE STRATEGIC REPORT FOR THE YEAR ENDED 31 MARCH 2024 

## Trustee Declaration 

So far as the Trustees are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the Company’s Auditors are unaware, and each Trustee has taken all the steps that they ought to have taken as a Trustee to make themselves aware of any relevant audit information and to establish that the Company’s Auditors are aware of that information. 

The Trustees’ Report incorporating the Strategic Report was approved by the Board of Trustees on 26/9/2024 2024 and signed on its behalf by: 

Michael Rymer Chairperson 

Christopher Thomas Trustee 

- 6 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

- ! 

- ! 

- ! 

- ! 

- ! 

- ! 

- ! 

- ! 

- ! 

- ! ! 

- ! 

- ! 

- ! 

- ! 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## INDEPENDENT AUDITORS' REPORT TO THE TRUSTEES OF THE MARTLETS HOSPICE LIMITED 

We have audited the financial statements of The Martlets Hospice Limited (‘the charitable company’) for the year ended 31 March 2024 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Charity Balance sheet, the Consolidated Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice). 

In our opinion the financial statements: 

- give a true and fair view of the state of the group's and the parent charitable company’s affairs as at 31 March 2024 and of the group's incoming resources and application of resources, including its income and expenditure, for the year then ended; 

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and 

- have been prepared in accordance with the requirements of the Companies Act 2006. 

## Basis for opinion 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs(UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the audit of financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## Emphasis of matter - Financial statements prepared on a basis other than Going Concern 

We draw attention to Note 1.3 to the financial statements which explains that the directors intend to liquidate the company and therefore do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly the financial statements have been prepared on a basis other than going concern as described in Note 1.3. Our opinion is not modified in respect of this matter. 

## Other Information 

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard. 

- 8 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## INDEPENDENT AUDITORS' REPORT TO THE TRUSTEES OF THE MARTLETS HOSPICE LIMITED 

## Opinions on other matters prescribed by the Companies Act 2006 

In our opinion, based on the work undertaken in the course of the audit: 

- the information given in the trustees’ annual report for the financial year for which the financial statements are prepared is consistent with the financial statements; and 

- the strategic report and the trustees’ annual report have been prepared in accordance with applicable legal requirements. 

## Matters on which we are required to report by exception 

In the light of the knowledge and understanding of the group and the charitable company and its environment obtained in the course of the audit, we have not identified any material misstatements in the strategic report and the annual trustees' report. 

We have nothing to report in respect of the following matters where the Companies Act 2011 requires us to report to you if, in our opinion: 

- the information given in the Trustees’ Annual Report is inconsistent in any material respect with the financial statements; or 

- the charity has not kept adequate accounting records; or 

- the financial statements are not in agreement with the accounting records and returns; or 

- we have not received all the information and explanations we require for our audit. 

## Responsibilities of trustees 

As explained more fully in the trustees’ responsibilities statement set out on page 12, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so. 

## Auditor’s responsibilities for the audit of the financial statements 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below. 

- 9 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## INDEPENDENT AUDITORS' REPORT TO THE TRUSTEES OF THE MARTLETS HOSPICE LIMITED 

## Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud 

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the charity. 

Our approach was as follows: 

- we obtained an understanding of the legal and regulatory requirements applicable to the charity and considered that the most significant are the Charities Act 2011, the Charity SORP, and UK financial reporting standards as issued by the Financial Reporting Council; 

- we obtained an understanding of how the charity complies with these requirements by discussions with management and those charged with governance; 

- we assessed the risk of material misstatement of the financial statements, including the risk of material misstatement due to fraud and how it might occur, by holding discussions with management and those charged with governance; 

- we inquired of management and those charged with governance as to any known instances of noncompliance or suspected non-compliance with laws and regulations; 

- based on this understanding, we designed specific appropriate audit procedures to identify instances of non-compliance with laws and regulations. This included making enquiries of management and those charged with governance and obtaining additional corroborative evidence as required. 

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also: 

- identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control; 

- obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the charity’s internal control; 

- • evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the trustees; 

- conclude on the appropriateness of the trustees’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the charity’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the charity to cease to continue as a going concern; 

- evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation. 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. 

- 10 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## INDEPENDENT AUDITORS' REPORT TO THE TRUSTEES OF THE MARTLETS HOSPICE LIMITED 

## Use of our report 

This report is made solely to the charitable company's members as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to any party other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinion we have formed. 

## James Saunders (Senior Statutory Auditor) 

for and on behalf of Moore Kingston Smith LLP, Statutory Auditor 

Betchworth House 57-65 Station Road Redhill Surrey RH1 1DL Date 4/10/2024 

- 11 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED 

## CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING THE INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2024 

|Note<br>INCOME AND ENDOWMENTS:<br>Donations and legacies<br>2<br>Charitable activities<br>3<br>Other trading activities<br>4<br>Income from investments<br>5<br>Total Income and Endowments<br>EXPENDITURE:<br>Raising funds<br>6<br>Charitable activities<br>7<br>Total Expenditure<br>Net gains/ (losses) on investments<br>Taxation<br>Net Surplus/ (Deficit)<br>Transfers between funds<br>Net movement in funds<br>Reconciliation of Funds<br>Balance brought forward<br>Balance carried forward<br>21<br>Net Surplus/ (Deficit) before other recognised gains and<br>losses|General<br>£<br>5,141,136<br>2,705,470<br>4,228,653<br>35,064<br>12,110,323<br>2,525,808<br>9,848,947<br>12,374,755<br>(264,432)<br>(15,000)<br>-<br>(279,432)<br>(718,674)<br>(998,106)<br>2,296,558<br>1,298,452<br>Unrestri|Designated<br>£<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>3,914,329<br>3,914,329<br>7,000,000<br>10,914,329<br>202<br>cted Funds|Restricted<br>Funds<br>£<br>2,001,206<br>-<br>5,354<br>-<br>2,006,560<br>-<br>1,173,809<br>1,173,809<br>832,751<br>-<br>-<br>832,751<br>(3,195,655)<br>(2,362,904)<br>2,369,857<br>6,953<br>4|Total<br>Funds<br>£<br>7,142,342<br>2,705,470<br>4,234,007<br>35,064<br>14,116,883<br>2,525,808<br>11,022,756<br>13,548,564<br>568,319<br>(15,000)<br>-<br>553,319<br>-<br>553,319<br>11,666,415<br>12,219,734|General<br>£<br>2,004,595<br>2,692,917<br>3,223,273<br>180,718<br>8,101,503<br>2,268,287<br>9,225,459<br>11,493,746<br>(3,392,243)<br>(247,694)<br>-<br>(3,639,937)<br>-<br>(3,639,937)<br>5,936,495<br>2,296,558<br>Unrestric|Designated<br>£<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>7,000,000<br>7,000,000<br>202<br>ted Funds|Restricted<br>Funds<br>£<br>77,631<br>-<br>676,163<br>-<br>753,794<br>-<br>99,446<br>99,446<br>654,348<br>-<br>-<br>654,348<br>-<br>654,348<br>1,715,509<br>2,369,857<br>3|Total<br>Funds<br>£<br>2,082,226<br>2,692,917<br>3,899,436<br>180,718<br>8,855,297<br>2,268,287<br>9,324,905<br>11,593,192<br>(2,737,895)<br>-<br>(247,694)<br>-<br>(2,985,589)<br>-<br>(2,985,589)<br>14,652,004<br>11,666,415|
|---|---|---|---|---|---|---|---|---|



The statement of financial activities includes all gains and losses recognised in the year and all income and expenditure derive from continuing activities. The Hospice has a surplus for the year of £642,674 (2023: £2,870,383). 

The notes on pages 21 to 37 form part of these financial statements. 

- 12 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED CONSOLIDATED BALANCE SHEET FOR THE YEAR ENDED 31 MARCH 2024 

|Notes<br>Fixed assets:<br>Tangible assets<br>12<br>Intangible assets<br>13<br>Investment property<br>11<br>Investments<br>14|£|2024|£<br>10,914,329<br>-<br>-<br>-|£|2023|£<br>7,147,117<br>-<br>1,500,000<br>-|
|---|---|---|---|---|---|---|
|Total fixed assets<br>Current assets:<br>Stock<br>16<br>Debtors<br>17<br>Cash at bank and in hand|24,815<br>2,666,578<br>755,919||10,914,329|30,977<br>2,588,029<br>2,190,038||8,647,117|
|Total current assets<br>Liabilities:<br>Creditors: Amounts falling due<br>within one year<br>18|3,447,312<br>(2,073,055)|||4,809,044<br>(1,746,739)|||
|Net current assets|||1,374,257|||3,062,305|
|Total assets less current liabilities<br>Creditors: Amounts falling due in<br>greater than one year<br>19<br>Net assets|||12,288,586<br>(68,853)<br>12,219,734|||11,709,422<br>(43,008)<br>11,666,415|
|The funds of the charity:<br>Restricted funds<br>21<br>Unrestricted funds<br>21<br>Designated funds<br>21|||6,953<br>1,298,452<br>10,914,329|||2,369,857<br>2,296,558<br>7,000,000|
|Total funds|||12,219,734|||11,666,415|



## 26/9/2024 

These financial statements were approved by the members of the Board of Trustees on ………………… and signed on their behalf by: 

Michael Rymer BO007357FE3A94EA... Christopher Thomas Trustee Secretary 

Charity number: 802145 Company number: 02326410 (England and Wales) 

The notes on pages 21 to 37 form part of these financial statements. 

- 13 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED CHARITY BALANCE SHEET FOR THE YEAR ENDED 31 MARCH 2024 

|Notes<br>Fixed assets:<br>Tangible assets<br>12<br>Intangible assets<br>13<br>Investment property<br>11<br>Investments<br>14|£|2024|£<br>10,914,329<br>-<br>-<br>2|£|2023|£<br>7,125,678<br>-<br>1,500,000<br>2|
|---|---|---|---|---|---|---|
|Total fixed assets<br>Current assets:<br>Debtors<br>17<br>Cash at bank and in hand|2,737,724<br>608,932||10,914,331|2,658,456<br>2,075,421||8,625,680|
|Total current assets<br>Liabilities:<br>Creditors: Amounts falling due within one<br>year<br>18|3,346,656<br>(1,869,838)|||4,733,877<br>(1,611,150)|||
|Net current assets|||1,476,818|||3,122,727|
|Total assets less current liabilities<br>Creditors: Amounts falling due in greater<br>than one year<br>19|||12,391,149<br>-|||11,748,407<br>-|
|Net assets|||12,391,149|||11,748,407|
|The funds of the charity:<br>Restricted funds<br>21<br>Unrestricted funds<br>Designated funds|||6,953<br>12,384,196<br>-|||2,369,857<br>2,378,550<br>7,000,000|
|Total funds|||12,391,149|||11,748,407|



26/9/2024 These financial statements were approved by the members of the Board of Trustees on ………………… and signed on their behalf by: MidraclSigned by: Rumer rl DocuSigned by: B007357FE3A94EA... 6B60A64E39EC45A... Michael Rymer Christopher Thomas Trustee Secretary 

These financial statements were approved by the members of the Board of Trustees on ………………… and signed on their behalf by: 

Charity number: 802145 Company number: 02326410 (England and Wales) 

The notes on pages 21 to 37 form part of these financial statements. 

- 14 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED CONSOLIDATED STATEMENT OF CASHFLOWS FOR THE YEAR ENDED 31 MARCH 2024 


**----- Start of picture text -----**<br>
Notes 2024 2023<br>£ £<br>Cash flows from operating activities:<br>Net cash provided by operating activities 24 2,441,026 (1,557,950)<br>Cash flows from investing activities:<br>Dividends and interest receivable 35,064 180,718<br>Purchase of tangible fixed assets (5,410,209) (4,133,409)<br>Proceeds from sale of investments and fixed assets - 2,244,511<br>Proceeds from sale of investment properties 1,500,000 540,000<br>Proceeds from maturity of investment portfolio - 1,277,470<br>Net cash provided by investing activities (3,875,145) 109,290<br>Change in cash and cash equivalents in<br>the reporting period (1,434,119) (1,448,660)<br>Cash and cash equivalents at the<br>beginning of the reporting period 2,190,038 3,638,698<br>Cash and cash equivalents at the end<br>of the reporting period 25 755,919 2,190,038<br>**----- End of picture text -----**<br>


- 15 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 1 ACCOUNTING POLICIES 

## Company Information 

The Martlets Hospice Limited is a charitable company, limited by guarantee, registered in England and Wales. The charitable company's registered number and registered office address can be found in the Legal and Administrative information section of the accounts. 

The Group consists of Martlets Hospice Limited and its two subsidiaries, The Martlets Trading Co Limited and Martlets Care Limited. 

## 1.1 Basis of Preparation 

A summary of the principal accounting policies adopted, judgements and key sources of estimation uncertainty, is set out below. 

The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and with the Companies Act 2006, The Charities Act 2011 and follows the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland ('the SORP'). The financial statements have been prepared on the historical basis except for the modification to a fair value basis for certain financial instruments as specified in the accounting policies below. 

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound. 

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below. 

## 1.2 Basis of consolidation 

The results of The Martlets Trading Co Limited and Martlets Care Limited have been consolidated on a line by line basis. The results for the subsidiaries are disclosed in note 15. As permitted by s408 Companies Act 2006, the Hospice has not presented its own Statement of Financial Activities and related notes. 

## 1.3 Going concern 

At the Balance Sheet date the group had net assets of £12,219,734 including cash balances of £2,666,578. On the 1st February 2024 an agreement was reached to make the group part of St Barnabas Hospice meaning the company is expected to be liquidated in due course. Due to this the trustees have made the assessment that the financial statements are prepared on a basis other than going concern. 

## 1.4 Incoming resources 

Grants are recognised as income over the period to which they relate. Any grant funding received in advance is recognised as deferred income on the balance sheet. 

Legacies are recognised following probate and once there is sufficient evidence that receipt is probable and the amount of the legacy receivable can be measured reliably. Where entitlement to a legacy exists but there is uncertainty as to its receipt or the amount receivable, details are disclosed as a contingent asset until the criteria for income recognition are met. 

All other incoming resources are recognised when the charity is entitled to the income, there is certainty of receipt and the monetary value can be measured with reasonable accuracy. 

- 16 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 1 ACCOUNTING POLICIES (CONTINUED) 

## 1.5 Government grant receivable 

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. 

## 1.6 Donated goods 

Donated goods and services have not been recognised in these financial statements as it is not practicable to do so as the cost outweighs the benefit. 

## 1.7 Resources expended and the basis of allocation of costs 

Expenditure is accounted for on an accruals basis. Overheads and other costs not directly attributable to particular projects are apportioned to the relevant funds on the basis of management estimates of the amount attributable to that activity in the year, either by reference to staff, time or space occupied, as appropriate. 

Costs relating to a particular activity are allocated directly and others are apportioned on an appropriate staff basis. All costs are allocated between the expenditure categories of the Statement of Financial Activities on a basis designated to reflect the use of the resources. 

## 1.8 Fixed assets 

Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less estimated residual value, over the expected useful life on the following basis: 

- Leasehold buildings straight line over 30 years - Furniture & equipment straight line over 4 years Motor vehicles - straight line over 4 years - Computer equipment straight line over 4 years 

At the end of each accounting period the residual values and useful lives of assets are reviewed and adjusted if necessary. In addition, if events or change in circumstances indicate that the carrying value may not be recoverable then the carrying values of tangible fixed assets are reviewed for impairment. 

Assets under construction are not depreciated until the asset is brought into use. 

Assets are written off to the Statement of Financial Activities once their net book value becomes less than £5,000. 

## 1.9 Intangible fixed assets 

Intangible fixed assets are stated at cost less amortisation. Amortisation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life as follows: 

Website 

- 25% straight line 

Assets are written off to the Statement of Financial Activities once their net book value becomes less than £5,000. 

## 1.10 Stock 

Stock is stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stock to their present location and condition. 

Stock held for distribution at no or nominal consideration is measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential. 

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stock over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss. 

- 17 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 1 ACCOUNTING POLICIES (CONTINUED) 

## 1.11 Investments 

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals are recognised immediately in profit or loss. 

A subsidiary is an entity controlled by the charitable company. Control is the power to govern the financial and operating policies of the intity so as to obtain benefits from its activities. 

## 1.12 Financial assets 

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method, unless arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at k t t f i t t 

## 1.13 Financial liabilities 

Basic financial liabilities are initially measured at transaction price. 

## 1.14 Leases 

Rent payable under operating leases is accounted for in the Statement of Financial Activities in equal amounts over the period of the lease. 

## 1.15 Taxation 

The Martlets Hospice Limited is registered as a charity and all its income falls within the exemptions under Part 11 of the Corporation Tax Act 2010. Any tax changed incurred by the Group is based on taxable profit for the year and included as a liability at the balance sheet date where necessary. 

## 1.16 Deferred taxation 

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the Statement of Financial Activities, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority. 

- 18 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 1 ACCOUNTING POLICIES (CONTINUED) 

## 1.17 Pension costs and other post-retirement benefits 

The Martlets Hospice Limited operates a defined benefit pension scheme and a defined contribution pension scheme for its staff. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate. 

The Martlets Hospice Limited is one of many employers in the NHS Pension Scheme. It is, therefore, not possible to allocate any actuarial surplus or deficit and, consequently, contributions to the NHS Pension Scheme are charged to the Statement of Financial Activities in the year in which they fall due for payment. The scheme has both defined benefits and contributions, any shortfall in the national fund being met by the Exchequer. 

## 1.18 Fund accounting 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Designated funds are funds set aside by Trustees to be used for a specific purpose. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

## 1.19 Critical accounting judgements and key sources of estimation uncertainty 

In the application of the accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. 

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements. 

## 2 DONATIONS AND LEGACIES 

|Patient related donations<br>Legacies receivable<br>General donations from individuals<br>Corporate donations<br>Donated goods Gift Aid scheme<br>Charitable Trust donations|Unrestricted<br>Funds<br>£<br>203,040<br>1,337,040<br>591,404<br>89,040<br>94,351<br>2,826,261<br>5,141,136|Restricted<br>Funds<br>£<br>-<br>-<br>102,557<br>120<br>-<br>1,898,529<br>2,001,206|Total<br>2024<br>£<br>203,040<br>1,337,040<br>693,961<br>89,160<br>94,351<br>4,724,790<br>7,142,342|Total<br>2023<br>£<br>271,269<br>620,657<br>306,981<br>112,647<br>66,981<br>703,691<br>2,082,226|
|---|---|---|---|---|



- 19 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 


**----- Start of picture text -----**<br>
3 INCOME FROM CHARITABLE ACTIVITIES<br>Unrestricted Restricted Total Total<br>Funds Funds 2024 2023<br>£ £ £ £<br>-<br>CCG grants 2,648,502 2,648,502 2,621,045<br>-<br>COVID-19 grants 2,047 2,047 29,338<br>Other services 54,922 - 54,922 42,534<br>-<br>2,705,470 2,705,470 2,692,917<br>4 INCOME FROM OTHER TRADING ACTIVITIES<br>Unrestricted Restricted Total Total<br>Funds Funds 2024 2023<br>£ £ £ £<br>-<br>Shop sales 1,642,756 1,642,756 1,474,196<br>Online sales 102,682 - 102,682 103,466<br>-<br>Recycled sales 44,544 44,544 44,121<br>New Goods sales 120,721 - 120,721 71,313<br>-<br>Care packages 696,246 696,246 713,681<br>-<br>Respite packages 95,262 95,262 123,368<br>Functions and events income 863,361 5,354 868,715 690,991<br>Collection boxes 9,184 - 9,184 10,912<br>-<br>Lottery income 653,896 653,896 667,388<br>4,228,653 5,354 4,234,007 3,899,436<br>5 INVESTMENT INCOME<br>Unrestricted Restricted Total Total<br>Funds Funds 2024 2023<br>£ £ £ £<br>Dividend income 8,648 - 8,648 79,645<br>Interest income 18,989 - 18,989 30,281<br>Rental income 7,427 - 7,427 70,792<br>-<br>35,064 35,064 180,718<br>6 EXPENDITURE ON RAISING FUNDS<br>Unrestricted Restricted Total Total<br>Funds Funds 2024 2023<br>£ £ £ £<br>Activities undertaken directly<br>Staff costs 1,357,217 - 1,357,217 1,272,120<br>Other costs 490,537 - 490,537 403,806<br>-<br>1,847,754 1,847,754 1,675,926<br>Support costs<br>Staff costs 114,590 - 114,590 135,058<br>Other costs 563,464 - 563,464 457,304<br>-<br>678,054 678,054 592,362<br>-<br>2,525,808 2,525,808 2,268,288<br>**----- End of picture text -----**<br>


- 20 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

|7<br>EXPENDITURE ON CHARITABLE ACTIVITIES<br>Activities undertaken directly<br>Staff costs<br>Other costs<br>Support<br>Staff costs<br>Other costs<br>8<br>ANALYSIS OF SUPPORT COSTS<br>Staff costs<br>Printing and stationery<br>Advertising<br>Legal and professional fees<br>Auditor's remuneration<br>Conference and training<br>Computer running costs<br>Service contracts<br>Repairs and renewals<br>Security<br>Travel and motor costs<br>Rent and rates<br>Heat and light<br>Telephone costs<br>Insurance<br>Subscription costs<br>Investment management<br>Bank charges<br>Other costs<br>Depreciation costs<br>Impairment costs|Unrestricted<br>Funds<br>£<br>5,000,039<br>476,297<br>5,476,336<br>1,919,483<br>2,453,128<br>4,372,611<br>9,848,947<br>Unrestricted<br>funds<br>£<br>2,034,073<br>46,588<br>34,044<br>206,067<br>20,614<br>33,782<br>488,321<br>21,056<br>99,110<br>494<br>59,773<br>948,236<br>135,895<br>38,030<br>67,613<br>15,661<br>-<br>39,782<br>157,410<br>629,963<br>1,013,035<br>6,089,547|Restricted<br>Funds<br>£<br>69,692<br>65,237<br>134,929<br>-<br>1,038,880<br>1,038,880<br>1,173,809<br>Restricted<br>funds<br>£<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-|Total<br>2024<br>£<br>5,069,731<br>541,534<br>5,611,265<br>1,919,483<br>3,492,008<br>5,411,491<br>11,022,756<br>Total<br>2024<br>£<br>2,034,073<br>46,588<br>34,044<br>206,067<br>20,614<br>33,782<br>488,321<br>21,056<br>99,110<br>494<br>59,773<br>948,236<br>135,895<br>38,030<br>67,613<br>15,661<br>-<br>39,782<br>157,410<br>629,963<br>1,013,035<br>6,089,547|Total<br>2023<br>£<br>4,279,297<br>481,024<br>4,760,321<br>2,399,594<br>2,164,989<br>4,564,583<br>9,324,905<br>Total<br>2023<br>£<br>2,534,652<br>51,375<br>50,020<br>122,337<br>21,524<br>68,827<br>408,787<br>20,528<br>22,518<br>2,551<br>52,259<br>1,245,853<br>184,852<br>34,473<br>61,879<br>15,331<br>16,426<br>31,707<br>84,786<br>126,260<br>-<br>5,156,945|
|---|---|---|---|---|



Included within Support Costs above are Governance Costs. These costs include auditor's remuneration of £20,614 (2023: £21,524). 

## 9 STAFF COSTS 

|Wages and salaries<br>Social security costs<br>Pension costs|2024<br>£<br>7,245,951<br>656,979<br>534,541<br>8,437,471|2023<br>£<br>6,895,637<br>653,262<br>513,539<br>8,062,438|
|---|---|---|



The average monthly number of employees (full time equivalent) during the year was as follows: 

|Direct charitable activities<br>Administration<br>Fundraising<br>Martlets Care Limited<br>The Martlets Trading Co Limited|2024<br>Number<br>128<br>39<br>11<br>42<br>34<br>254|2023<br>Number<br>124<br>58<br>14<br>49<br>34<br>279|
|---|---|---|



- 21 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## **THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024** 

## **9 STAFF COSTS (continued)** 

The number of employees whose emoluments, excluding pension contributions, were over £60,000 during the year were: 

|£60,000 - £70,000<br>£70,000 - £80,000<br>£80,000 - £90,000<br>£90,0000 - £100,000<br>£100,000 - £110,000<br>£120,000 - £130,000<br>£140,000 - £150,000<br>£160,000 - £170,000<br>£180,000 - £190,000|**2024**<br>**£**<br>3<br>2<br>2<br>-<br>-<br>1<br>1<br>1<br>-<br>10|**2023**<br>**£**<br>3<br>3<br>1<br>1<br>1<br>-<br>-<br>1<br>1<br>11|
|---|---|---|



Of the employees whose emoluments exceed £60,000, 6 (2023: 6) have retirement benefits accruing under defined benefit pension schemes. Pension contributions for higher paid employees in the year amounted to £76,184 (2023: £92,812). 

The key management personnel of the parent charitable company comprise the Chief Executive, Director of Income Generation, Director of Finance and Support Services, Director of Clinical Services and the Director of People Services. 

During the year key management personnel received total remuneration of £511,996 (2023: £713,845). 

## **10 TRUSTEE REMUNERATION** 

The trustees did not receive any remuneration during the year (2023 - £nil). Trustees received reimbursement of expenses in the year of £nil (2023 - £422). 

## **11 INVESTMENT PROPERTY** 

|**CHARITY AND GROUP**<br>**Fair Value**<br>At 1 April 2023<br>Disposed<br>Revaluation<br>**At 31 March 2024**|**£**<br>1,500,000<br>(1,500,000)<br>-<br>**-**|
|---|---|



- 22 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 12 TANGIBLE FIXED ASSETS 

|GROUP<br>Cost:<br>At 1 April 2023<br>Additions<br>Impairment<br>At 31 March 2024<br>Depreciation:<br>At 1 April 2023<br>Charge for the year<br>Impairment losses<br>At 31 March 2024<br>Net Book Value:<br>At 31 March 2024<br>At 31 March 2023<br>CHARITY<br>Cost:<br>At 1 April 2023<br>Additions<br>Disposals<br>Impairment<br>At 31 March 2024<br>At 1 April 2023<br>Charge for the year<br>Impairment losses<br>At 31 March 2024<br>Net Book Value:<br>At 31 March 2024<br>At 31 March 2023<br>Transfer of assets<br>brought to use<br>Transfer of assets<br>brought to use<br>Adjustment in relation to<br>prior year<br>Adjustment in relation to<br>prior year|Asset Under<br>Construction<br>£<br>4,641,173<br>5,331,357<br>-<br>(9,972,530)<br>-<br>-<br>-<br>-<br>-<br>-<br>4,641,173<br>Asset Under<br>Construction<br>£<br>4,641,173<br>5,331,357<br>-<br>-<br>(9,972,530)<br>-<br>-<br>-<br>-<br>-<br>-<br>4,641,173|Leasehold<br>buildings<br>£<br>3,837,547<br>-<br>(1,851,714)<br>9,712,585<br>11,698,418<br>1,450,453<br>274,319<br>239,120<br>(847,309)<br>1,116,583<br>10,581,835<br>2,387,094<br>Leasehold<br>buildings<br>£<br>3,837,547<br>-<br>-<br>(1,851,714)<br>9,712,585<br>11,698,418<br>1,450,453<br>274,319<br>239,120<br>(847,309)<br>1,116,583<br>10,581,835<br>2,387,094|Furniture &<br>equipment<br>£<br>372,788<br>-<br>(344,784)<br>259,945<br>287,949<br>333,692<br>36,772<br>23,914<br>(344,492)<br>49,886<br>238,063<br>39,096<br>Furniture &<br>equipment<br>£<br>319,623<br>-<br>-<br>(291,622)<br>259,945<br>287,946<br>293,177<br>24,120<br>23,914<br>(291,328)<br>49,883<br>238,063<br>26,446|Computer<br>equipment<br>£<br>405,274<br>78,852<br>(220,399)<br>-<br>263,727<br>340,220<br>(2,518)<br>45,667<br>(214,073)<br>169,296<br>94,431<br>65,054<br>Computer<br>equipment<br>£<br>405,274<br>78,852<br>-<br>(220,399)<br>-<br>263,727<br>340,220<br>(2,518)<br>45,667<br>(214,073)<br>169,296<br>94,431<br>65,054|Motor<br>vehicles<br>£<br>61,428<br>-<br>(61,428)<br>-<br>-<br>46,727<br>6,877<br>5,812<br>(59,416)<br>-<br>-<br>14,701<br>Motor<br>vehicles<br>£<br>40,593<br>-<br>-<br>(40,593)<br>-<br>-<br>34,682<br>4,038<br>1,873<br>(40,593)<br>-<br>-<br>5,911|Total<br>£<br>9,318,210<br>5,410,209<br>(2,478,325)<br>-<br>12,250,094<br>2,171,092<br>315,450<br>314,513<br>(1,465,290)<br>1,335,765<br>10,914,329<br>7,147,118<br>Total<br>£<br>9,244,210<br>5,410,209<br>-<br>(2,404,328)<br>-<br>12,250,091<br>2,118,532<br>299,959<br>310,574<br>(1,393,303)<br>1,335,762<br>10,914,329<br>7,125,678|
|---|---|---|---|---|---|---|



Impairment has been recognised this year due to the old hospice building being written off now the construction work on the new building has been completed and some smaller items where the net book value had dropped below £5,000. There has also been a change in the depreciation policy during the year to align the policy with St Barnabas Hospice's policy. 

- 23 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 13 INTANGIBLE FIXED ASSETS 

|Website costs<br>Cost:<br>At 1 April 2023<br>Additions<br>At 31 March 2024<br>Depreciation:<br>At 1 April 2023<br>Charge for the year<br>At 31 March 2024<br>Net Book Value:<br>At 31 March 2024<br>At 31 March 2023|GROUP<br>£<br>38,900<br>-<br>38,900<br>38,900<br>-<br>38,900<br>-<br>-|CHARITY<br>£<br>20,000<br>-<br>20,000<br>20,000<br>-<br>20,000<br>-<br>-|
|---|---|---|



## 14 FIXED ASSET INVESTMENTS 

|Cost:<br>At 1 April 2023<br>Additions<br>Disposals<br>Revaluations<br>Transfers<br>At 31 March 2024|Subsidiary<br>Total<br>Investments<br>£<br>2<br>2<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>2<br>2<br>CHARITY|
|---|---|



## At 31 March 2024 

The subsidiary undertakings included as investment at the balance sheet date are: 

|Name of Company|Class of Shares|Holdings|Nature of Business|
|---|---|---|---|
|Martlets Care Limited|Ordinary|100%|Provides welfare services and|
||||care|
|The Martlets Trading Co Limited|Ordinary|100%|Retail sale of goods|



- 24 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 15 SUBSIDARY COMPANIES 

## 15a Martlets Care Limited 

The Hospice owns a subsidiary, Martlets Care Limited (company number 06250709). 

|Income statement<br>Turnover<br>Cost of sales|2024<br>2023<br>£<br>£<br>791,508<br>837,049<br>(566,870)<br>(563,943)|
|---|---|
|Gross profit<br>Operating expenses<br>Other operating income|224,638<br>273,106<br>(215,718)<br>(220,503)<br>2,131<br>8,907|
|Net profit<br>Gift aid donated to hospice|11,051<br>61,510<br>(11,051)<br>(61,510)|
|Profit for the financial year being the retained profit|-<br>-|
|Balance sheet<br>Assets<br>Liabilities|2024<br>2023<br>£<br>£<br>390,104<br>445,032<br>(381,934)<br>(386,403)|
|Net assets|8,170<br>58,629|
|Represented by:<br>Capital<br>Reserves|1<br>1<br>8,169<br>58,628|
||8,170<br>58,629|
|15b<br>The Martlets Trading Co Limited<br>2024<br>2023<br>Income statement<br>£<br>£<br>Turnover<br>1,852,625<br>1,660,179<br>Cost of sales<br>(83,273)<br>(36,568)<br>The Hospice owns a subsidiary, The Martlets Trading Co Limited (company number<br>04557282).||
|Gross profit<br>Operating expenses<br>Other operating income<br>Interest receivable|1,769,352<br>1,623,611<br>(1,616,669)<br>(1,457,286)<br>10,774<br>30,103<br>-|
|Profit / (Loss) before tax<br>Taxation|163,457<br>196,428<br>-<br>-|
|Net profit<br>Gift aid donated to hospice|163,457<br>196,428<br>(163,457)<br>(196,428)|
|Profit for the financial year|-<br>-|



- 25 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 15b Martlets Tading Co Limited (continued) 

|Balance sheet<br>Assets<br>Liabilities<br>Net assets<br>Represented by:<br>Capital<br>Reserves<br>16.<br>STOCK<br>Shop stock<br>17<br>DEBTORS<br>Trade debtors<br>Amounts due from group companies<br>Prepayments and accrued income<br>Social security and other taxes<br>Other debtors|2024<br>2023<br>£<br>£<br>24,815<br>30,977<br>2024<br>2023<br>£<br>£<br>667,941<br>670,879<br>-<br>-<br>1,839,691<br>1,414,430<br>80,510<br>467,941<br>78,436<br>34,780<br>2,666,578<br>2,588,030<br>GROUP<br>GROUP|2024<br>2023<br>£<br>£<br>478,979<br>394,710<br>(511,942)<br>(394,709)<br>(32,963)<br>1<br>1<br>1<br>(32,964)<br>-<br>(32,963)<br>1<br>2024<br>2023<br>£<br>£<br>-<br>-<br>2024<br>2023<br>£<br>£<br>406,588<br>443,338<br>620,974<br>582,433<br>1,651,606<br>1,168,952<br>58,031<br>447,033<br>525<br>16,700<br>2,737,724<br>2,658,456<br>CHARITY<br>CHARITY|
|---|---|---|



Included within prepayments and accrued income is legacy income receivable of £1,495,285 (2023: £1,175,426) due to the Charity. 

## 18 CREDITORS: Amounts falling due within one year 

|2024<br>2023<br>£<br>£<br>Trade creditors<br>96,574<br>811,194<br>Amounts due to St Barnabas Hospice<br>1,005,322<br>-<br>Accruals and deferred income<br>621,817<br>579,431<br>Social security and other taxes<br>156,598<br>159,371<br>Other creditors<br>192,744<br>196,742<br>2,073,055<br>1,746,738<br>GROUP|2024<br>2023<br>£<br>£<br>51,561<br>798,040<br>1,005,322<br>-<br>559,938<br>546,677<br>133,905<br>141,822<br>119,112<br>124,611<br>1,869,838<br>1,611,150<br>CHARITY|
|---|---|



- 26 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 18 CREDITORS: Amounts falling due within one year (continued) 

|Deferred income<br>Balance as at 1 April 2023<br>Movement in the year<br>Balance as at 31 March 2024|GROUP<br>£<br>417,512<br>4,060<br>421,572|CHARITY<br>£<br>394,849<br>6,107<br>400,956|
|---|---|---|



## 19 CREDITORS: Amounts falling due after 1 year. 

|Other creditors|2024<br>2023<br>£<br>£<br>68,853<br>43,008<br>68,853<br>43,008<br>GROUP|2024<br>2023<br>£<br>£<br>-<br>-<br>-<br>-<br>CHARITY|
|---|---|---|



## 20 PENSION COMMITMENTS 

- The Charity operated three pension schemes during the year on behalf of its employees. - NHS Superannuation Scheme 

- Royal London 

Contributions to each scheme are charged to the Statement of Financial Activities as they arise. 

Royal London: This is a defined contribution scheme. The assets of the scheme are held separately from Group in a fund independently administered by Royal London and the assets and liabilities of the scheme are therefore represented in the Group accounts. 

NHS Superannuation Scheme: The Group makes contributions to the scheme for nursing and medical staff. The scheme is an approved multi-employer scheme and, as such, the Group is not able to identify its share of the assets or of the potential liability it may have to the scheme at the balance sheet date. 

- 27 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 20 PENSION COMMITMENTS (continued) 

The total contributions made by the Group were as follows: 

|Martlets Group Personal Pension Plans<br>NHS Defined Benefit Scheme||2024<br>2023<br>2024<br>2023<br>£<br>£<br>£<br>£<br>286,255<br>278,774<br>230,833<br>228,025<br>248,286<br>234,765<br>248,286<br>234,765<br>GROUP<br>CHARITY|
|---|---|---|
|||534,541<br>513,539<br>479,119<br>462,790|
|Total contributions outstanding at the year-end amounted to<br>RESERVES<br>At 1 April 2023<br>£<br>Unrestricted funds<br>General funds<br>2,296,558<br>Restricted funds<br>Capital Funds<br>Hospice Development<br>1,286,032<br>Renaissance Project<br>253,006<br>Renovations Fund<br>22,598<br>Gateways to Care Project<br>46,621<br>IPU Equipment<br>11,469<br>MBE Project<br>711,163||£78,308 (2023: £79,653) for the Group and Charity.<br>Income<br>Expenditure<br>Transfers<br>At 31 March 2024<br>£<br>£<br>£<br>£<br>12,110,323<br>(12,389,755)<br>(718,674)<br>1,298,452<br>-<br>(735,969)<br>550,063<br>-<br>-<br>-<br>(240,793)<br>12,213<br>-<br>-<br>-<br>(7,638)<br>14,960<br>-<br>-<br>-<br>(46,621)<br>-<br>-<br>-<br>(11,469)<br>-<br>-<br>1,907,256<br>-<br>2,618,419<br>-<br>-|
|2,330,889<br>Revenue Funds<br>Carers Project<br>6,500<br>Hospice at Home<br>6,000<br>Heads On Charity/ NHS Charities Togethe<br>7,200<br>Other<br>19,268||1,907,256<br>(1,042,490)<br>3,195,655<br>-<br>-<br>37,850<br>(44,128)<br>-<br>222<br>37,324<br>(43,324)<br>-<br>-<br>-<br>(7,200)<br>-<br>-<br>24,130<br>(36,667)<br>-<br>6,731|
|Total restricted funds<br>Designated funds<br>Hospice Development<br>Tangible fixed assets|38,968<br>2,369,857<br>7,000,000<br>-|99,304<br>(131,319)<br>-<br>6,953<br>2,006,560<br>(1,173,809)<br>3,195,655<br>-<br>6,953<br>-<br>-<br>(7,000,000)<br>-<br>-<br>-<br>10,914,329<br>10,914,329|
||7,000,000|-<br>-<br>3,914,329<br>10,914,329|
|Total funds|11,666,415|14,116,883<br>(13,563,564)<br>-<br>12,219,734|



## 21 RESERVES 

## Restricted funds 

Transfers to and from capital restricted funds relate to a correction made to align net book values of assets funded with restricted fund balances shown. 

## Hospice Development 

This asset fund represents the Hospice building. It appears as a restricted fund because the original capital appeal to build the Hospice was conducted by MacMillan Cancer Support. On completion the asset was then given to the Charity with the restriction that it was to be used only as a Hospice. The expenditure shown during the year represents depreciation and rent paid to the NHS who owns the land. The Hospice building is also represented in our fixed asset schedule. 

## Renaissance Project 

A capital grant was provided by NHS England in 2013 to create new day service facilities including a café and three multi-functional rooms. Improvements were also made to our main entrance and drugs room. Additional sums were raised from charitable trusts. The expenditure in the year represents depreciation on capital assets forming part of the appeal. 

- 28 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 21 RESERVES (continued) 

## Restricted funds (continued) 

## Renovation Fund 

The Martlets Hospice has embarked on building works to reconfigure the rear entrance to the building to enhance the passage and experience for patients entering the inpatient unit. 

## Gateway to Care Project 

A capital grant was provided by the Department of Health in 2008 to refurbish our Reception and Day Hospice facilities. The expenditure represents depreciation on capital assets forming part of the appeal. 

## IPU Equipment 

IPU equipment was purchased from a restricted donation in 2019. 

## MBE Project 

Funds have been received which are restricted to the Martlets Building Enhancement Project. This project is now complete. 

## Carers Project 

The Ernest Kleinwort Charitable Trust has awarded a grant to Martlets to deliver a project that aims to provide better support for Carers. 

## Hospice at Home 

This cash fund represents our Hospice at Home service and shows the income and expenditure of restricted grants and donations in the year. 

## Heads on Charity/ NHS Charities Together 

A £100,000 grant was awarded to Sussex hospices from Heads On Charity/NHS Charities Together to support clinical nurse specialists caring for people at end of life in their own homes. Martlets Hospice is the lead charity responsible for delivering the project and distributing the grant amongst the 7 Sussex Hospices. The project term is 1 year from 1 November 2021 to 31 October 2022 but the grant is payable over a longer 3 financial year term - 2021 to 2024. 

## Others 

These cash funds represent the income and expenditure of restricted donations made during the year for various purposes. 

## Designated funds 

## Hospice Development 

This fund represents funds set aside by Trustees to be used to partially fund the Martlets Building Enhancement project which is now complete. 

- 29 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 22 ANALYSIS OF NET ASSETS 

|As at 31 March 2024<br>Unrestricted Funds<br>Restricted Funds<br>Designated Funds<br>Unrestricted Funds<br>Restricted Funds<br>Designated Funds<br>As at 31 March 2023<br>Unrestricted Funds<br>Restricted Funds<br>Designated Funds<br>Unrestricted Funds<br>Restricted Funds<br>Designated Funds|Fixed assets<br>£<br>-<br>-<br>10,914,329<br>10,914,329<br>Fixed assets<br>£<br>-<br>-<br>10,914,329<br>10,914,329<br>Fixed assets<br>£<br>5,459,133<br>1,687,984<br>-<br>7,147,117<br>Fixed assets<br>£<br>5,441,210<br>1,684,468<br>-<br>7,125,678|£<br>£<br>-<br>1,298,452<br>-<br>6,953<br>-<br>-<br>-<br>1,305,405<br>£<br>£<br>-<br>1,469,865<br>-<br>6,953<br>2<br>-<br>2<br>1,476,818<br>£<br>£<br>-<br>(3,162,575)<br>-<br>681,873<br>1,500,000<br>5,500,000<br>1,500,000<br>3,019,298<br>£<br>£<br>-<br>(3,062,660)<br>-<br>685,389<br>1,500,002<br>5,499,998<br>1,500,002<br>3,122,727<br>GROUP<br>Fixed asset<br>investments<br>Other net<br>assets<br>CHARITY<br>Fixed asset<br>investments<br>Other net<br>assets<br>Fixed asset<br>investments<br>Other net<br>assets<br>GROUP<br>Fixed asset<br>investments<br>Other net<br>assets<br>CHARITY|Total<br>£<br>1,298,452<br>6,953<br>10,914,329<br>12,219,734<br>Total<br>£<br>1,469,865<br>6,953<br>10,914,331<br>12,391,149<br>Total<br>£<br>2,296,558<br>2,369,857<br>7,000,000<br>11,666,415<br>Total<br>£<br>2,378,550<br>2,369,857<br>7,000,000<br>-<br>11,748,407|
|---|---|---|---|



- 30 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 23 SHARE CAPITAL 

The company has no share capital and is limited by guarantee. 

## 24 RECONCILIATION OF NET INCOME/(EXPENDITURE) TO NET CASH FLOW FROM OPERATING ACTIVITIES 

|Net income/(expenditure) for the<br>reporting period<br>Adjustments for:<br>Depreciation of tangible fixed assets<br>Losses/(Gains) on investments<br>Impairment of fixed assets<br>Revaluation of investment properties<br>Investment income<br>(Increase)/ decrease in stocks<br>(Increase)/decrease in debtors<br>Increase/(decrease) in creditors<br>Net cash provided by/(used in)<br>operating activities<br>25<br>ANALYSIS OF CASH AND CASH EQUIVALENTS<br>Cash in hand<br>Total cash and cash equivalents|2024<br>£<br>553,319<br>629,963<br>-<br>1,013,035<br>-<br>(35,064)<br>6,162<br>(78,548)<br>352,161<br>2,441,026<br>755,919<br>755,919|2023<br>£<br>(2,985,588)<br>126,260<br>162,486<br>-<br>85,208<br>(180,718)<br>(15,365)<br>748,842<br>500,925<br>(1,557,950)<br>2,190,038<br>2,190,038|
|---|---|---|



## 26 OPERATING LEASES 

At 31st March the Group had annual commitments under operating leases as set out below: 

|Within 1 year<br>Between 2 and 5 years<br>After five years|2024<br>£<br>270,385<br>318,256<br>1,695,847<br>2,284,488|2023<br>£<br>739,948<br>335,092<br>1,701,800<br>2,776,840|
|---|---|---|



- 31 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

## THE MARTLETS HOSPICE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 27 RELATED PARTY TRANSACTIONS 

## GROUP 

There were no related party transactions in the year. 

## CHARITY 

During the year Martlets Care Limited declared a gift aid payment of £61,510 (2023: £158,663) to The Martlets Hospice Limited, its parent company. During the year, rent payments totalling £3,600 (2023: £nil) were made to The Martlets Hospice Limited, its parent company. At the year end £307,842 (2023: £298,269) was outstanding from the company. This balance includes a loan of £188,000 due to The Martlets Hospice Limited. Interest of 0.75% per annum above LIBOR is payable on the loan balance. 

During the year The Martlets Trading Co Limited declared a gift aid payment of £196,421 (2023: £nil) to The Martlets Hospice Limited, its parent company. During the year, rent payments totalling £12,000 (2023: £nil) were made to The Martlets Hospice Limited, its parent company. At the year end £313,132 (2023: £284,164) was outstanding from the company. This balance includes a loan of £125,000 due to The Martlets Hospice Limited. Interest of 0.75% per annum above LIBOR is payable on the loan balance. 

During the year Martlets Hospice Limited received a loan from St Barnabas Hospice, its parent company, of £1,000,000. 

Interest at the Bank of England base rate is due on the loan balance, at 5.25% at year end. The total balance outstanding to the parent company at year end was £1,005,322 (2023: £nil) 

## 28 CAPITAL COMMITMENTS 

Amounts contracted for but not provided in the financial statements: 

|Acquisition of assets under construction|2024<br>£<br>-<br>-|2023<br>£<br>4,868,913<br>4,868,913|
|---|---|---|



## 29 PARENT COMPANY 

The ultimate parent company of The Martlets Hospice Limited is the St Barnabas Hospices (Sussex) Ltd, a charitable company incorporated in England and Wales. 

- 32 - 



Docusign Envelope ID: 94B3DDEE-BC6B-41F0-820C-BF9B85284EA4 

